| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 751.27M | 751.27M | 551.19M | 444.18M | 451.15M | 318.21M |
| Gross Profit | 578.05M | 578.05M | 400.06M | 43.54M | 311.85M | 221.55M |
| EBITDA | 56.98M | 56.98M | 43.11M | 32.50M | 32.54M | 27.28M |
| Net Income | 35.37M | 35.37M | 19.26M | 13.41M | 13.56M | 13.35M |
Balance Sheet | ||||||
| Total Assets | 470.97M | 470.97M | 288.15M | 227.42M | 231.98M | 155.56M |
| Cash, Cash Equivalents and Short-Term Investments | 94.32M | 94.32M | 100.97M | 46.74M | 27.88M | 34.18M |
| Total Debt | 51.74M | 51.74M | 29.25M | 27.73M | 27.17M | 19.88M |
| Total Liabilities | 311.19M | 311.19M | 166.98M | 122.44M | 138.56M | 97.85M |
| Stockholders Equity | 159.78M | 159.78M | 121.17M | 104.98M | 93.42M | 57.71M |
Cash Flow | ||||||
| Free Cash Flow | 107.82M | 107.82M | 68.90M | 32.09M | 6.60M | -4.30M |
| Operating Cash Flow | 120.93M | 120.93M | 82.84M | 37.79M | 11.47M | 6.99M |
| Investing Cash Flow | -46.36M | -46.36M | -15.82M | -7.31M | -24.25M | -12.42M |
| Financing Cash Flow | -16.21M | -14.72M | -12.79M | -11.48M | 6.33M | -189.08K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | AU$651.64M | 20.43 | 16.18% | 3.11% | 45.23% | 43.94% | |
73 Outperform | AU$1.13B | 31.51 | 25.18% | 0.58% | 36.30% | 82.20% | |
72 Outperform | AU$710.93M | 16.67 | 8.35% | 4.30% | -21.57% | -34.09% | |
71 Outperform | AU$709.72M | 20.43 | 50.61% | 5.37% | 12.96% | 8.19% | |
67 Neutral | AU$1.14B | 30.25 | 7.98% | 1.80% | 1.81% | -23.89% | |
66 Neutral | AU$1.79B | 35.57 | 13.62% | 1.92% | 23.76% | 21.18% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
GenusPlus Group Ltd. has announced a change in the director’s interest notice involving David William Riches. The change involves the acquisition of 357,277 fully paid ordinary shares valued at $1,800,000 as contingent consideration for the acquisition of shares in Partum Engineering Pty Ltd. This transaction reflects a strategic move by GenusPlus to consolidate its interests, potentially impacting its operational dynamics and stakeholder relationships.
GenusPlus Group Ltd announced the release of 2,460,937 fully paid ordinary shares from voluntary escrow, linked to its acquisition of Partum Engineering Pty Ltd. This release signifies a strategic move following the acquisition, with 357,277 shares remaining under escrow until December 2026, potentially impacting shareholder value and market perception.
GenusPlus Group Ltd has announced the quotation of 357,277 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of December 1, 2025. This move is part of a previously announced transaction, potentially enhancing the company’s market presence and providing additional liquidity for stakeholders.
GenusPlus Group Ltd has announced the appointment of Tony Narvaez as a director, effective from November 21, 2025. The Initial Director’s Interest Notice reveals that Tony Narvaez currently holds no relevant interests in securities, either as a registered holder or otherwise, and has no interests in contracts related to the company. This announcement is part of the company’s compliance with ASX listing rules, ensuring transparency in its governance practices.
GenusPlus Group Ltd. held its Annual General Meeting on November 20, 2025, where several key resolutions were voted on. The meeting resulted in the approval of the remuneration report, the re-election of director Simon High, and the issuance of contingent consideration shares to David Riches and Matthew Riches under the Partum transaction. These outcomes reflect strong shareholder support for the company’s current management and strategic direction.
GenusPlus Group Ltd held its 2025 Annual General Meeting, highlighting a record year with a Total Shareholder Return of 101% and a significant increase in cash position. The company announced the addition of Tony Narvaez to its board, whose expertise in energy and infrastructure is expected to enhance the company’s strategic direction and strengthen its ability to deliver long-term value.
GenusPlus Group Ltd has appointed Tony Narvaez as a Non-Executive Independent Director, effective November 21, 2025. With extensive experience in the energy sector, including leadership roles at AusNet Services and other major energy companies, Narvaez is expected to bring valuable insights to GenusPlus. His appointment is anticipated to bolster the company’s strategic direction in the energy and infrastructure sectors, particularly as the industry undergoes rapid transformation with increasing opportunities in renewables and advanced technologies.
GenusPlus Group Ltd. has announced the issuance of 131,207 fully paid ordinary securities to be quoted on the Australian Securities Exchange (ASX). This move, part of an employee incentive scheme, reflects the company’s strategy to enhance employee engagement and align their interests with shareholders. The issuance may strengthen GenusPlus Group’s market position by potentially increasing liquidity and demonstrating a commitment to rewarding its workforce.
GenusPlus Group Ltd has announced the cessation of certain securities, specifically 93,376 performance rights and 99,708 share appreciation rights. These securities have lapsed due to the conditions not being met or becoming incapable of being satisfied, which may impact the company’s capital structure and investor perceptions.
GenusPlus Group Ltd has released its corporate governance statement for the financial year ending 30 June 2025, which is available on their website. The statement confirms compliance with the ASX Corporate Governance Council’s principles and recommendations, detailing the company’s adherence to governance practices and outlining any deviations. This disclosure is significant for stakeholders as it provides transparency into the company’s governance framework and practices, potentially impacting investor confidence and the company’s market positioning.
GenusPlus Group Ltd has announced a proposed issue of 357,277 fully paid ordinary securities, with the issue date set for November 26, 2025. This move is part of the company’s strategy to enhance its capital structure, potentially impacting its market positioning and offering new opportunities for stakeholders.
GenusPlus Group Ltd has announced its Annual General Meeting (AGM) scheduled for 20 November 2025, to be held in Perth, Western Australia. Shareholders can participate by attending in person or voting by proxy, with the company encouraging active participation. This meeting is significant for stakeholders as it provides an opportunity to engage with the company’s board and discuss resolutions, reflecting GenusPlus Group’s commitment to transparency and shareholder involvement.
GenusPlus Group Ltd has been awarded three significant contracts by Fortescue Metals Group as part of Fortescue’s decarbonisation initiatives in Western Australia. The contracts, valued at approximately $60 million, involve the construction of transmission lines and power distribution infrastructure at Fortescue’s mining sites, with completion expected by the fourth quarter of 2026. This collaboration underscores GenusPlus’s ongoing commitment to supporting Fortescue’s efforts to achieve Real Zero terrestrial emissions by 2030, enhancing its position as a key player in the power and communications infrastructure industry.
GenusPlus Group Ltd has been awarded additional work under its contract with Western Power for the Clean Energy Link – North project, valued at approximately $50 million. This project aims to enhance the transmission network capacity in Western Australia to support renewable energy integration. Additionally, GenusPlus secured a $25 million contract for the Network Renewal Underground Power Pilot project, further strengthening its partnership with Western Power and reinforcing its position in the power infrastructure industry.
GenusPlus Group Ltd has announced its Annual General Meeting (AGM) will take place on 20 November 2025 in Perth, where the re-election of directors will be a key agenda item. The closing date for director nominations is set for 13 October 2025, marking a crucial timeline for stakeholders interested in the company’s governance. This meeting is significant as it will influence the company’s leadership and potentially its strategic direction.
GenusPlus Group Ltd has announced the application for quotation of 610,483 ordinary fully paid securities on the Australian Securities Exchange (ASX). These securities are issued under an employee incentive scheme and are not subject to transfer restrictions. This move is expected to enhance the company’s market presence and provide liquidity options for its stakeholders.
GenusPlus Group Ltd. has announced a change in the director’s interest notice involving David William Riches. The change involved the disposal of 1,350,000 fully paid ordinary shares through an on-market trade, valued at $7,425,000. This adjustment in shareholding reflects a strategic move by the director, which may influence stakeholder perceptions and the company’s market positioning.